KATmt is the first identified cAMP regulated protein lysine acetylase in mycobacteria. Results: KATmt acylates fatty acyl CoA ligases in vivo in a cAMP dependent manner, thus regulating their activity. Conclusion: Mycobacteria utilize KATmt to regulate the metabolic pool of acetyl and propionyl CoA. Significance: We provide novel paradigms for linking cAMP signaling and fatty acid metabolism in mycobacteria.
SUMMARY
Acetylation of lysine residues is a posttranslational modification that is used by both eukaryotes and prokaryotes to regulate a variety of biological processes. Here we identify multiple substrates for the cAMP-dependent protein lysine acetyltransferase (KATmt) from Mycobacterium tuberculosis. We demonstrate that a catalytically important lysine residue in a number of FadD enzymes is acetylated by KATmt in a cAMP-dependent manner, and acetylation inhibits the activity of FadD enzymes. A sirtuin-like enzyme can deacetylate multiple FadDs, thus completing the regulatory cycle. Using a strain deleted for the KATmt ortholog in M. bovis BCG, we show for the first time that acetylation is dependent on intracellular cAMP levels. KATmt can utilize propionyl CoA as a substrate, and therefore plays a critical role in alleviating propionyl CoA toxicity in mycobacteria by inactivating acyl CoA synthase. The precision by which mycobacteria can regulate metabolism of fatty acids in a cAMPdependent manner appears to be unparalleled in other biological organisms, and is ideally suited to adapt to the complex environment that pathogenic mycobacteria experience in the host.
_______________________________________
Tuberculosis remains one of the leading causes of death due to an infectious disease. The causative agent of tuberculosis, Mycobacterium tuberculosis (Mtb), is harboured by almost 30 % of the world's population. However, most infected people do not develop the disease. Thus, a delicate balance is maintained between the pathogen and a healthy host that does not show signs of illness. This balance can tilt towards the pathogen if the host is co infected with HIV, or has a weakened immune response due to dietary or environmental conditions, and understanding the factors that disturb the equilibrium is therefore important.
A number of virulence factors in Mtb allow it to evade the natural immune response of the host, establish infection, and remain persistent over many years in a dormant state. The availability of the genome sequence of Mtb served as an important molecular tool in dissecting the roles of individual genes in pathogenesis (1) . We found some years ago that a number of genes involved in cAMP (3',5' cAMP) synthesis (adenylyl cyclases) were encoded in many mycobacterial genomes (2, 3) . Cyclic AMP, a universal second messenger, provides a means by which the pathogen can communicate with and hijack host signaling within macrophages during early infection (4, 5) . Indeed, it has been reported that deletion of one of the sixteen adenylyl cyclase genes in Mtb results in attenuation of virulence (6) , pointing towards an important role for cAMP/adenylyl cyclases in Mtb pathogenesis.
Elevated cAMP levels are, however, also seen in non pathogenic strains of mycobacteria, indicating that cAMP has important roles to play in the basic biology of mycobacteria (7) . We therefore set out to identify targets of cAMP in mycobacteria, and focused on proteins that contained a cyclic nucleotide binding (CNB) domain, earlier identified and characterized in many eukaryotic proteins and the bacterial transcription factor, CRP (8, 9) . We identified unique proteins (MSMEG_5458 and Rv0998) from M. smegmatis and M. tuberculosis respectively, that consisted of a CNB domain fused to an acetyltransferase domain. We demonstrated that these proteins act as cAMP regulated protein lysine acetyltransferases (10) , and showed that a universal stress protein (USP) is a substrate in M. smegmatis.
Rv0998, which we call KATmt, required the presence of cAMP to show acetyl transferase activity.
Recent biophysical and structural analyses revealed the dramatic conformational change that occurs in these proteins on cAMP binding that allows the acetylation of its protein substrates (11, 12) .
Orthologs of KATmt are found in all mycobacteria, including M. leprae, indicating that this protein must have an important role to play in these organisms. The fusion of a CNB domain along with an acetyltransferase domain in a single gene product is not found in any other prokaryotic or eukaryotic genome sequenced thus far, implying that the direct regulation of protein acetylation by intracellular cAMP levels in mycobacteria is unique to this genus. In the current study we have identified substrates of KATmt and show for the first time that a number of mycobacterial fatty acyl Co A ligases (FACLs) are acylated in vitro and in vivo by KATmt. We thus perhaps uncover some of the first mechanisms downstream of adenylyl cyclases and cAMP within mycobacteria, during establishment, and possibly persistence, in the host macrophage.
EXPERIMENTAL PROCEDURES

Bioinformatic analysis
Six amino acids surrounding the acetylated Lys residue in USP were used as a seed sequence for BLASTP analysis against the predicted M. tuberculosis protein database (NCBI). Proteins that were identified were then manually inspected to confirm that the Lys residue was preceded by a small amino acid and followed by a few small hydrophobic residues (13). Proteins that were identified were then subjected to further analysis using Predmod (www.cs.cornell.edu/w8/~amrita/predmod.html) (13).
Multiple sequence alignment of the 34 FadDs was done using ClustalW (14, 15) , and a phylogenetic tree was generated using MEGA (16) . Cloning, expression and purification of proteins The list of primers used for PCR and mutagenesis are provided in supplemental Table S1 . All clones were generated and verified by sequencing (Macrogen, South Korea). Cloning strategies are available on request. A clone of FadD13 containing a mutation at Lys517 was kindly provided by Prof. A.K. Tyagi. University of Delhi.
Proteins were expressed in the E. coli BL21 endo strain following induction with 500 M isopropyl beta thio galactopyranoside (IPTG) for 20 h at 16º C or for 3 h at 37°C, as described earlier (10) . For MSMEG_5175 (sirtuin) and MSMEG_5175 H104Y , cells were lysed in lysis buffer containing 50 mM Tris Cl (pH 8.2), 500 mM NaCl, 20% glycerol, 5 mM 2 ME, 2 mM PMSF and 1 mM benzamidine. Washes were done with buffer containing 50 mM Tris Cl (pH 8.2), 500 mM NaCl, 20% glycerol, 5 mM 2 ME and 20 mM imidazole. The proteins were eluted with buffer containing 50 mM Tris Cl (pH 8.2), 500 mM NaCl, 20% glycerol, 5 mM 2 ME and 300 mM imidazole.
KATmt was expressed in the E. coli SP850 strain on induction using 500 M IPTG for 20 h at 16º C as described earlier (10) . Western blotting Samples were electrophoresed on a 12% SDS polyacrylamide gel and transferred to PVDF membrane (Immobilon P, Millipore). FadD13 polyclonal antibody was generated in the laboratory and used at a dilution of 1:5000. Acetyl lysine antibody (Cell Signaling Technologies, USA) was used at a dilution of 1:2500. Horseradish peroxidase conjugated secondary antibody (GE Healthcare) or light chain specific antibody (Jackson ImmunoResearch Laboratories, USA) were used and detected by Enhanced Chemiluminescence as per the manufactures instructions (GE Healthcare).
Mass Spectrometric Analysis
Recombinant purified protein samples after in vitro acylation were treated with 400 ng of trypsin for 5 h in solution. The peptide mixtures were then analysed by liquid chromatography and electrospray tandem mass spectrometry (LC ESI MS/MS). The samples were analyzed on a HCT Ultra ETD II ion trap mass spectrometer (Bruker Daltonics, Bremen, Germany), coupled to an Agilent 1100 HPLC. The LC separation was performed on reverse phase C18 column, at a flow rate of 0.2 ml/min, using H 2 O ACN (with 0.1% formic acid) solvent system under a gradient of 90% H 2 O to 90% ACN over a period of 60 min. The mass spectral analysis was performed under Auto MSMS conditions, with three most intense ions from each scan being subjected to CID fragmentation. The fragmentations were carried out inside the ion trap through the collision of He gas with the ions of interest, which were excited kinetically by an increased resonance amplitude of the dipolar field, with a value typically set between 1 2V. The scan speed was set at 26,000 m/z s 1. The m/z range for MS detection and MS/MS precursor ion selection were set from 300 1800 and 500 1400, respectively. In vitro deacylation assay FadDs (2 µg) were acetylated or propionylated by KATmt (200 ng). Samples were then directly treated with sirtuin WT or sirtuin H104Y (500 ng) in the presence or absence of 1 mM NAD + . Deacetylation reactions were carried out at 37°C in buffer containing 25 mM Tris Cl (pH 8.2), 137 mM NaCl, 2.7 mM KCl, 1 mM MgCl 2 and 100 ng/µl BSA for 1 h. Whenever necessary, deacetylation reactions were also performed in the presence of 5 mM nicotinamide (NAM), a known sirtuin enzyme inhibitor. Reactions were stopped by boiling in SDS sample buffer and analyzed by western blotting with acetyl lysine antibody and chemiluminescent HRP substrate (Immobilon, Millipore). FadD assays The activities of acylated or non acylated FadDs were assessed using an in vitro fatty acyl CoA synthetase assay with 14 C labelled palmitic acid as the substrate. The purified FadD protein (1 µg) was initially incubated with 10 mM DTT for 30 min at 37°C prior to its use. Subsequently, purified enzymes were incubated with 50 µM acetyl CoA or propionyl CoA, 25 mM Tris Cl (pH 7.5), 1 mM cAMP and 300 ng of KATmt for 30 min at 37°C to acylate the FadDs in a reaction volume of 10 µl.
Fatty acyl CoA synthetase assays were performed in 50 mM Tris Cl (pH 8.0), 100 µM 14 C palmitic acid, 5 mM ATP and 2.5 mM MgCl 2 in a 10 µl reaction volume and, wherever applicable, CoA (2 mM). After pre warming the reaction mixture at 30°C for 15 min, purified protein (acetylated or non acetylated) was added to a final reaction volume of 20 µl and incubated for 5 min at 30°C. The reactions were quenched with 5% acetic acid and directly spotted on silica gel TLC plates. Products were resolved in n butanol/acetic acid/water (15:5:8) at 4°C. The radioactive bands on TLC were detected using a phosphoimager (Bass 1800, Fuji) after 12 h of exposure.
Mycobacterial cell culture and preparation of cell lysates M. bovis BCG was grown in Middlebrook's 7H9 broth supplemented with 0.2% glycerol, 10% ODAC (oleic acid, albumin, dextrose and catalase) and 0.03% Tyloxapol (Sigma Aldrich, USA). Initially the cultures were maintained in volume of 5 ml in tissue culture flasks (T 25 cm2, Thermo Scientific, USA) without shaking till the optical density (OD) reached 1. This culture was then used as inoculum for large scale cultures, with an initial OD of 0.1. Whenever necessary, hygromycin (50 g/ml) was used. For carbon utilisation experiments, bacteria were grown in 7H9 medium containing 0.03% Tyloxapol and glucose (0.2%). Sodium propionate was used at a concentration of 10 mM. For SDS stress, cells were grown till the OD was 0.8 and then treated with 0.05% SDS for 1.5 h at 37°C.
For preparation of whole cell lysates, cells were broken by bead beating in buffer containing 10 mM Tris Cl (pH 7.5), 100 mM NaCl, 10% glycerol, 5 g/ml leupeptin, 5 g/ml aprotinin, 5 g/ml soybean trypsin inhibitor, 3 mM nicotinamide, and 1 M trichostatin A. Nonidet P 40 and deoxycholate to final concentrations of 1% and 0.5%, respectively, were added to the lysate and mixed continuously at 4°C for 2 h, following which samples were centrifuged for 30 min at 4°C at 13,000g. Supernatants were collected, and protein was estimated using a Micro BCA protein assay kit (Invitrogen). Measurement of cAMP in M. bovisBCG Cells were centrifuged at 13,000g and washed with buffer containing 10 mM Tris Cl (pH 7.5), 0.89% NaCl, and 0.05% Tween 80 (TBST), the pellet was resuspended in 0.1N HCl and the suspension was boiled for 10 min. Aliquots of the lysate were taken for estimation of cAMP by radioimmunoassay. Immunoprecipitation of FadD13 Antibodies to FadD13 was generated in rabbits. Anti FadD 13 IgG was purified using T Gel purification kit (Thermo Scientific Pierce, USA) as per manufacturer's instructions. For pre clearing, cell lysates (300 µg) were incubated with normal rabbit IgG for 1 h at 4°C. Protein G beads were added to the lysates and incubated for an additional 30 min. The beads were removed by centrifugation, and the pre cleared supernatant was interacted with FadD13 IgG overnight at 4°C. Protein G beads were added to the lysates and incubated for an additional 2 h. The beads were pelleted at 4°C and washed thrice with buffer containing 10 mM Tris Cl (pH 7.5), 100 mM NaCl and 0.1% Triton X 100 and twice with TBS (10 mM Tris Cl, pH 7.5, 100 mM NaCl). The beads were boiled in SDS sample buffer and subsequently analyzed by SDS PAGE and western blotting.
RNA isolation and Reverse Transcriptase PCR
Cells were harvested and resuspended in 300 µl Tri reagent (Sigma Aldrich, USA) pre warmed to 65 o C. Approximately 50 mg glass beads (with a diameter of 465 600 µm, Sigma Aldrich, USA) were added and bead beating carried out for 90 sec with 30 sec intervals at 4800 rpm using a BeadBeater (BioSpec Products, USA). The lysate was mixed by pipetting, followed by centrifugation at 12,000g for 10 min at 4°C. The supernatant was treated with chloroform (200 l) followed by centrifugation at 14,000g for 15 min at 4°C. The RNA was precipitated with 200 l of isopropyl alcohol, and the RNA pellet was dissolved, quantified and treated with RNase free DNase (1 to 5 units). RNA (2 g) was used for reverse transcription using 200 units of reverse transcriptase (MBI fermentas, Canada). The transcript levels of BCG_1055 (KATbcg), FadD13 and sirtuin were assessed using primer pairs Rv0998RTFWD and Rv0998RTRVS, Rv3089RTFWD and Rv3089RTRVS and Rv1151cRTFWD and Rv1151cRVS respectively (supplemental Table S1 ). Generation of KATbcg strain M. bovis BCG with a deletion of KATbcg was generated using allelic exchange using a specialized transducing phage phAE87 (kindly provided by Prof. Sabine Ehrt, Weill Cornell Medical College, USA). A region ~650 bp upstream of KATbcg was amplified using Rv0998upFWD and Rv0998upRVS primers (5' amplicon) (supplemental Table S1 ). Similarly a fragment ~650 bases downstream of KATbcg was amplified using Rv0998downFWD and Rv0998downRVS primers (3' amplicon) (supplemental Table S1 ) and fragments cloned into pBKSII (+) vector. Clones were confirmed by sequencing. The AgeI SphI fragment from pBKS Rv0998upKO was ligated to similarly digested pJSC284 loxP (kindly provided by Prof. Sabine Ehrt, Weill Cornell Medical College, USA) to generate pJSC284 loxP Rv0998upKO. The BamHI HindIII fragment from pBKS Rv0998downKO was ligated into similarly cut pJSC284 loxP Rv0998upKO plasmid to generate pJSC284 loxP Rv0998updownKO plasmid. The isolated phage DNA was ligated using 5 Weiss units of DNA ligase at 16°C for 12 h. After ligation the phage DNA was subjected to PacI digestion. The digested phage DNA was then ligated to PacI digested pJSC284 loxP Rv0998updownKO. The packaging of the ligated phage DNA was carried out in the laboratory of Dr. Apoorva Bhatt, School of Biosciences, University of Birmingham. Approximately 5 20 µg phagemid DNA was electroporated into electrocompetent M. smegmatis cells and plated on 7H10 agar plates. Plaques appeared 2 3 days later at 30°C. The phages were amplified and phage DNA was isolated to check the presence of pJSC284 loxP Rv0998updownKO by PCR. The desired phage was transduced into exponential phase M. bovis BCG and they were screened for the absence of KATbcg by genomic PCR using Rv0998FWD and Rv0998RVS primers (supplemental Table S1 ). They were further confirmed by Southern blotting and RTPCR.
To construct the KATbcg strain complemented with the KATbcg gene driven by its own promoter, Rv0998upFWD and Rv0998RVS primers (supplemental Table S1 ) were used to amplify KATbcg and 650 bp of upstream region. The PCR product was digested with BamHI and EcoRI and ligated into similarly digested pBKSII (+) to generate pBKS opromRv0998. The NotI EcoRI fragment from pBKS opromRv0998 was cloned into similarly digested pMV306 (a kind gift of Prof. Sabine Ehrt, Weill Cornell Medical College, USA) to generate pMV306 opromRv0998 which was electroporated in the KATbcg strain. Positive integrants carrying the required insert were screened by colony PCR and validated by Southern hybridization and RT PCR.
RESULTS
Multiple substrates for KATmt A loose consensus for predicting lysine residues that have a propensity for acetylation has been identified (13), and a stretch of small or flexible amino acid directly preceding the acetylated lysine residue is often observed (17, 18) . Therefore, we used 6 amino acids surrounding the acetylated Lys residue in USP as a seed sequence for BLASTP analysis against the predicted M. tuberculosis protein database. Proteins that were identified were then manually inspected to confirm that the Lys residue was preceded by a small amino acid and followed by a few small hydrophobic residues, as seen in the USP sequence. Sixty proteins were thus identified and were then subjected to further analysis using Predmod (www.cs.cornell.edu/w8/~amrita/predmod.html) to determine their propensity for acetylation (13). Eighteen proteins had a significant score (supplemental Fig. 1a) , suggesting that these proteins may be acetylated by KATmt.
We selected 7 proteins, cloned their genes and expressed all of them in E. coli (supplemental Fig. 1b) . Rv2948c (FadD22), Rv0270 (FadD2), Rv3089 (FadD13), Rv0166 (FadD5) are acyl CoA synthetases, Rv1007c is predicted to be a methionyl tRNA synthetase, Rv1633 is an enzyme involved in nucleotide excision repair, and Rv0640 is a 50S ribosomal protein L11. We also cloned Rv3667 (ACS) which has been shown earlier to be acetylated by the M. smegmatis KAT, MSMEG_5458 (19) .
Purified proteins were individually treated with KATmt in the presence of cAMP and acetyl CoA (Fig. 1a) . The Mtb 50S ribosomal protein L11, Rv0640, was acetylated as purified, probably by an E. coli protein acetyltransferase (PAT), and showed no further increase in acetylation in the presence of KATmt. ACS was acetylated by KATmt in a cAMP dependent manner in agreement with earlier results. While FadD22 (Rv2948c), FadD2 (Rv0270), FadD5 (Rv0166) and FadD13 (Rv3089) were acetylated in a cAMP dependent manner, Rv1633 and Rv1007c were not acetylated by KATmt.
Therefore, we were able to identify KATmt substrates through sequence analysis with some degree of confidence, and as shown below, the predictive efficiency was better for the family of FADs which we chose to study in greater detail.
The biochemical and structural features of FadD13 have been recently described (20 22). We have therefore used it in further studies as a representative substrate for KATmt. We mapped the site of acetylation in FadD13 using LC MS/MS, and identified Lys487 as the acetylated residue (Fig.  1b) . In agreement with the LC MS/MS data, a mutant FadD13 (Lys487Ala) showed no acetylation in the presence of KATmt, cAMP and acetyl CoA (Fig. 1c and supplemental Fig. 1c) (23) . The site of acetylation of FadD22, FadD2 and FadD5 was the Lys residue present at a position equivalent to Lys487 in FadD13. Since this lysine residue is conserved in FadD enzymes, it was of interest to determine whether all these proteins were substrates for KATmt. We therefore cloned and expressed all the 34 FadD enzymes in E. coli. Twenty two proteins were purifiable from E. coli, while the remainder were localized to inclusion bodies (supplemental Fig 1d) . We tested all 22 proteins for their ability to be acetylated by KATmt in a cAMP dependent manner, and as shown in Fig. 1d, 8 enzymes were acetylated. The site of acetylation in these proteins, as analyzed by LC MS/MS (supplemental Fig. 1e ) was the Lys residue present at an equivalent position to Lys487 in FadD13 (Fig.  1e) . LC MS/MS also confirmed that the other 14 FadD enzymes were not acetylated (since peptides resulting from tryptic cleavage following the C terminal Lys residue could be detected; supplemental Fig. 1f) .
We aligned the sequences of the FadDs that were acetylated, as well as those that were not (Fig.  1e) . We observed the conservation of motifs GGXNX 4 EXE/D, E/DX 7 E/D, K/AXP, and PX 4 GK in the C terminal domain sequences of FadDs that were acetylated, while non acetylated FadDs showed conservation in some, but not all of these motifs together. This implies a concerted influence of a set of conserved residues in the C terminal domain of FadDs, rather than just residues in the immediate proximity of the acetylated lysine residue that determine substrate specificity. Acetylated FADs clustered together on a dendrogram built on a sequence alignment of the full length proteins (Fig. 1f ), while the non acetylated enzymes branched separately. Inspection of the dendrogram and sequences of the non purifiable enzymes allowed us to predict whether a protein could be acetylated or not by KATmt (supplemental Fig. 1g) . Since FadDs 1, 11, and 15 do not have the PX 4 GK motif, while FadDs 21 and 33 lack the K/AXP, E/DX 7 E/D and GGXNX 4 
Deacetylation of FadDs by a mycobacterial sirtuin
like enzyme Lysine acetylation is a reversible process (24, 25) and deacetylation can be carried out by the sirtuin class of deacetylases. Sirtuin like enzymes can be identified in bacterial genomes (25, 26) , and one such enzyme, the product of the Rv1151c gene, has been shown to deacetylate ACS (19) . We cloned and purified the ortholog of Rv1151c, from M. smegmatis, MSMEG_5175 (sirtuin), (the former being more difficult to purify; supplemental Fig. 2a,b) , and monitored its ability to deacetylate FadD13 (supplemental Fig. 2c ). Sirtuins are NAD + dependent enzymes and a critical His residue is present at the active site, which on mutation to Tyr, inactivates enzyme activity (27). As seen in Fig. 2a , sirtuin was able to deacetylate FadD13 only in the presence of NAD + while the sirtuin H104Y , lacking the catalytic residue showed no activity either in the presence or absence of NAD + . Inclusion of nicotinamide (NAM), an inhibitor of sirtuin like enzymes prevented the deacetylation of FadD13 (28) .
We then proceeded to test whether sirtuin could deacetylate all the FadD enzymes that we have previously shown to be acetylated by KATmt. As shown in Fig. 2b , all enzymes could be deacetylated, some more efficiently than others, perhaps being reflective of surtuin substrate specificity, or the presence of additional domains following the adenylation domain, as is seen in FadD22 (29). These results therefore indicate that the state of FadD acetylation in the cell could be dynamically regulated by KATmt and sirtuin.
Acylation inhibits the AMP ligase activity of FadD enzymes Lys487 in FadD13 has been shown to be critical for the binding of ATP prior to the formation of the adenylated fatty acid which is subsequently converted to the CoA derivative (20, 22) . Therefore, reversible acetylation of this critical catalytic residue and the equivalent Lys residues in the other FadD enzymes could regulate their biochemical activities.
The substrates of all the FadDs from mycobacteria have not been identified. However, three of the FadD enzymes (FadD13, FadD5 and FadD2) that were putative substrates for KATmt could charge palmitic acid to form the CoA derivative (Fig. 3a) , but to different extents. As shown in Fig. 3a , acetylation of all these enzymes by KATmt prevented the formation of palmitoyl AMP. Given the conservation of the Lys residue that is acetylated and its critical role in the formation of the fatty acyl AMP conjugate, we predict that the activities of all the FadD enzymes that serve as substrates for KATmt are inhibited following acetylation.
In addition to acetyl CoA, some protein acetyl/propionyl transferases can also utilize propionyl CoA, resulting in the propionylation of proteins (30) . Using FadD13 as a substrate, we demonstrated propionylation of the same Lys residue in FadD13 that was acetylated (Fig. 3b) , resulting in inhibition of the activity of FadD13, in a manner similar to that seen on acetylation (Fig. 3c) . We then tested whether the presence of propionyl CoA affected the utilization of acetyl CoA by KATmt. As shown in Fig. 3d , increasing concentrations of propionyl CoA in the presence of acetyl CoA inhibited the acetylation of FadD13, presumably leading to its propionylation and a reduction in immunoreactivity with the acetyl lysine antibody. Therefore, the relative levels of acetyl CoA or propionyl CoA in the cell could determine whether a substrate of KATmt is acetylated or propionylated.
Propionylated FadD13 showed a low cross reactivity with the acetyl lysine antibody used for western blot analysis (last lane in Fig. 3d ). We exploited this to determine whether sirtuin was able to depropionylate FadD13. As shown in Fig. 3e , we could detect efficient depropionylation of FadD13 by the sirtuin enzyme, thus providing evidence for a more general mechanism of protein acylation and 
In vivo acetylation of FadD13 in Mb BCG
The activity of KATmt is precisely regulated by cAMP, as revealed from biochemical assays (Fig. 1a) . We therefore extended these in vitro biochemical studies to monitor cAMP dependent acetylation and deacetylation of KATmt substrates in vivo. Cyclic AMP levels in mycobacteria are modulated depending on environmental conditions and growth media (7, 31) . The sequences of KATmt and its ortholog in M. bovis BCG, BCG_1055 (KATbcg) are identical, as are the sequences of FadD13 and its ortholog BCG_3114.
M. bovis BCG grown in glycerol containing media had 10 fold higher cAMP levels as compared to growth in glucose containing media (Fig. 4a) . We therefore monitored the acetylation status of FadD13 in cells grown under these conditions where intracellular levels of cAMP differed. Cells grown in glycerol showed robust acetylation of FadD13 while cells grown in glucose showed no acetylated FadD13 (Fig. 4b) , even though levels of the sirtuin ortholog BCG_1212c, and KATbcg were equivalent (Fig. 4c) . Therefore, there appears to be a correlation between the intracellular levels of cAMP and the activity of KATbcg in vivo, resulting in the subsequent acetylation of its substrates.
We treated cells grown in glucose with 0.05% SDS, a procedure which we have earlier shown results in an increase in intracellular cAMP in M. smegmatis (7) . Indeed, cAMP levels were elevated in M. bovis BCG cells more than10 fold following SDS treatment (Fig. 4d) . As shown in Fig. 4e, FadD13 was now found to be acetylated following SDS treatment. The levels of both sirtuin and FadD13 remained unaltered in the SDS treated cells (Fig. 4f) , while a 4 fold increase in the KATbcg transcript on SDS treatment was observed. This, together with the increase in intracellular cAMP seen on SDS treatment could now result in activation of KATbcg, and increased acetylation of FadD13 (Fig. 4d) .
We next generated a strain of M. bovis BCG that was deleted for KATbcg ( KATbcg; supplemental Fig. 3a) . Approximately 650 bp upstream of KATbcg, which would contain the promoter, was cloned along with the gene, and integrated into the knock out strain to generate a complemented strain. The genomic integrity of these strains was confirmed by Southern blot analysis (supplemental Fig. 3b) . The transcript for KATbcg was absent in the knock out strain, and transcript levels were restored to wild type levels in the complemented strain (supplemental Fig. 3c) . We grew cells in glycerol and monitored the acetylation status of FadD13 in these strains. As seen in Fig.  4g, FadD13 was not acetylated in the knock out strain, grown either in glycerol or glucose containing media. Acetylation was restored on complementation of KATbcg in glycerol containing media, to the extent seen in the wild type strain. These results therefore demonstrate that FadD13, and presumably other substrates of KATbcg, are acetylated exclusively by KATbcg, and not by any other protein acetyltransferase that may be present in the cell. As a consequence, there is a specific and exquisite regulation of cAMP dependent protein acetylation in mycobacteria, brought about by this unique acetyltransferase.
Deletion of KATbcg in Mb BCG leads to
compromised growth on propionate containing media Mycobacteria are sensitive to high levels of intracellular propionyl CoA, presumably because of the formation of toxic propionyl CoA metabolites (32 34). ACS from M. tuberculosis is equally efficient in converting acetate or propionate to their CoA derivatives (35) .
We hypothesized that inhibition of the activity of ACS by acylation via KATbcg may be an important way of regulating the accumulation of propionyl CoA in the cell. We first confirmed that ACS could be propionylated by KATmt in the presence of cAMP (Fig. 5a ). We then grew wild type, KATbcg and the KATbcg strain complemented with a wild type copy of KATbcg, in media containing either propionate or glucose as the sole carbon source. Growth of the KATbcg deletion strain was not compromised in media containing glucose (where acetyl CoA formation by glycolytic pathways would be predominant), but growth in propionate was dramatically reduced (Fig. 5b) . Growth could be restored to levels seen for the wild type strain following complementation with KATbcg. While cAMP levels in wild type cells grown in either propionate (2.7 ± 0.7 pmol/ml/OD) or glucose (Fig.  4a) were equivalent, the levels of KATbcg mRNA were significantly increased in cells grown in propionate (5.1 ± 0.25 fold as estimated by real time qRTPCR; Fig. 5c ). However, the mRNA levels of the sirtuin ortholog, BCG_1212c, remained similar. It is therefore likely that the high levels of intracellular propionyl CoA, that is found in cells grown in propionate as the sole carbon source, necessitate the propionylation of ACS by KATbcg resulting in its inactivation. This would prevent the further build up of propionyl CoA, thereby alleviating toxicity (Fig. 5d) .
DISCUSSION
In this study we have identified multiple substrates for cAMP dependent protein acylation in M. tuberculosis, and for the first time, demonstrated the relevance of this post translational modification in vivo. Protein acetylation in bacteria occurs widely, but mycobacteria appear to represent the first and so far the only case where acylation is directly regulated by cAMP. The presence of a sirtuin like enzyme completes the machinery required for modulating protein lysine acylation in vivo, thus allowing mycobacteria to regulate the activities of various proteins based on intracellular levels of cAMP, acetyl CoA, propionyl CoA and NAD + . Such sophistication in directly regulating protein acylation has not been reported till date.
Based on a sequence alignment of acetylated proteins, we were able to recognize conserved amino acids not only in the vicinity of the modified Lys residue, but also some distance upstream (Fig. 1e ). This appears to be a general feature of all other acetyltransferases (36) . A recent structural analysis of FadD13 shows that the Lys residue that is acetylated by KATmt is buried in the catalytic site of the protein (20). Thus, in order for it to be acetylated, a significant structural change needs to occur.
Perhaps the conservation of residues some distance away from the acylated Lys residue may allow an initial recognition of a substrate by KATmt thus determining the specificity of acylation, and also resulting in the required conformational change to expose the Lys residue that is acetylated.
Reversible protein lysine acetylation regulates diverse protein properties, including DNA protein interactions, protein protein interaction, subcellular localization, stability, and enzymatic activity (37 43). We show here in mycobacteria that a variety of proteins serve as substrates for KATmt, indicating that multiple processes are likely to be affected by cAMP dependent protein acetylation in these organisms as well.
Of the multiple FadDs encoded in mycobacterial genomes, only a subset of them appears to be substrates for KATmt, emphasizing again the non redundant properties of the FadD family of enzymes (Fig. 1f) . Interestingly, none of the FAALs, enzymes involved in adenylation of fatty acids prior to their modification by polyketide synthetases during mycobacterial cell wall synthesis (44), appear to be acetylated by KATmt. It is interesting to note that in eukaryotes, a number of mitochondrial metabolic enzymes are modified by acylation, including those involved in lipid beta oxidation (45,46) , reflective of what we see in mycobacteria.
The nutrients available to Mtb inside the host macrophage are restricted, and a number of studies have shown that fatty acids and cholesterol serve as the primary source of carbon (47 53). However, degradation of cholesterol and odd chain fatty acids leads to the generation of propionyl CoA that is toxic to these bacteria (32, 34) . There are multiple mechanisms by which the toxicity of propionyl CoA can be alleviated. Isocitrate lyase can utilize propionyl CoA to form succinate and pyruvate (32, 49) ; propionyl CoA carboxylase can generate methylmalonyl CoA that can enter the methylmalonyl pathway to produce succinyl CoA (33) ; and methylmalonyl CoA can also be used for the formation of mycobacterial cell wall lipids (54) . We show here that propionyl CoA can also be utilized by KATmt for propionylation of proteins, and importantly, this propionylation can be reversed by the sirtuin enzyme (Fig. 3d) . We propose that this allows the selective modification of proteins depending on the intracellular levels of propionyl CoA, acetyl CoA, cAMP and NAD + the latter being required for catalysis by the sirtuin. The precision by which Mtb can this regulate its metabolism appears to be unparalled and suited to the complex environment that it is likely to experience in the macrophage, during infection and persistence in the granuloma.
While growth in propionate containing media did not dramatically increase intracellular levels of cAMP, it appears that the cell is able to enhance protein acetylation by increasing the levels of KATmt mRNA (Fig. 5c) . The Mtb ACS has been biochemically characterized, and in contrast to other species, can utilize both acetate and propionate equally efficiently to generate their CoA derivatives (19, 35 ).
This appears to be an evolutionary adaptation of this enzyme which would allow the generation of propionyl CoA that can be used for a variety of cellular processes specifically in mycobacteria. However, under conditions of high concentrations of propionyl CoA, KATmt can propionylate and thereby inactivate ACS (Fig. 5d) , thus preventing the further increase in propionyl CoA levels, which would prove toxic to the cell.
The promiscuity of the KATmt in utilizing acetyl or propionyl groups for acylation make it particularly suited to be enlisted in homeostatic responses to counter environmental or nutritional conditions that lead to elevated levels of propionyl CoA. This acylation appears obligatory for the alleviation of the toxicity of propionyl CoA metabolites, by acting as a feed back loop for regulating propionyl CoA levels in the cell, thereby accounting for the poor growth of the KATbcg strain.
In conclusion, we propose that KATmt influences a number of pathways in mycobacteria.
Increases in intracellular cAMP, brought about by the enhanced activity of adenylyl cyclases, would result in the activation of KATmt. FACLs which degrade lipids (e.g. FadD13) (22) , regulate phenolic glycolipid synthesis (FadD22) (29,55) , and have a role to play in epithelial invasion (FadD2) (56) , recycling mycolic acids (FadD5) (57) , utilization of cholesterol (FadD3) (58) or in virulence (FadD10) (59) , are regulated by acylation in a cAMP dependent manner.
Enzymes involved in intermediary metabolism are also regulated by acetylation, including ACS. Since ACS generates acetyl CoA and propionyl CoA equally efficiently in mycobacteria, inhibition of its activity following acylation may have a critical role to play in alleviating the toxicity of high levels of propionyl CoA. All these mechanisms appear to be critically dependent on the levels of intracellular cAMP and/or KATmt, making KATmt an important contributor to mycobacterial physiology and possibly, pathophysiology. red box (lower panel) highlights the variation in the highly conserved K/AXP motif. The acetylated lysine is marked with a green dot in both panels. (f) Dendrogram of full length sequences of 34 FadDs. The acetylated and non acetylated FadDs are highlighted with green/red arcs respectively. Using the same colour code and an asterix, the potential of 12 FadDs to be acetylated by KATmt is predicted. (200 ng, 30 o C, 30 min) and then deacetylated using sirtuin (500 ng) in the presence of NAD + (1 mM) at 37 °C for 1 h, followed by western blotting with acetyl lysine antibody. 
